MRI  Vol.3 No.1 , February 2014
Effects of Anwei decoction on the protein expression of TFF in rats with chronic atrophic gastritis
ABSTRACT

Objective: To explore the effects of Anwei decoction (AD) on the protein expression of TFF in rats with chronic atrophic gastritis(CAG). Methods: Forty-eight healthy rats were randomly divided into 4 groups: normal control group, pathologic model group, Anwei Decoction group, and Weifuchun group. CAG was induced in rats with N-methy-N-nitro-N-nitrogua-nidine (MNNG). The protein expression of TFF in rats’ gastric mucosa was determined by immunohistochemistry. Results: Compared with that in the normal control group, the protein expression of TFF1 was significantly enhanced in the pathologic model, Anwei Decoction and Weifuchun groups (both P < 0.01). The protein expression level of TFF1 was significantly higher in the Anwei Decoction group than in the Weifuchun group (P < 0.01). Compared with the normal control group, the protein expression of TFF2 was significantly enhanced in the pathologic model, Anwei Decoction and Weifuchun groups (both P < 0.01). The protein expression level of TFF2 was significantly higher in the Anwei Decoction group than in the Weifuchun group (P < 0.01). In comparison with the pathologic model group, the protein expression of TFF3 was remarkably reduced in Anwei Decoction and Weifuchun groups (both P < 0.01). but there was no difference between the group of Anwei decoction and the group of Weifuchun (P > 0.05). Conclusion: Anwei decoction may be effective in the treatment of CAG by enhancing the protein expression of TFF1, TFF2 while reducing that of TFF3 in gastric mucosas.


Cite this paper
Wei, W. , Lin, S. and Zhu, Y. (2014) Effects of Anwei decoction on the protein expression of TFF in rats with chronic atrophic gastritis. Modern Research in Inflammation, 3, 1-6. doi: 10.4236/mri.2014.31001.
References
[1]   Gastroenterology Branch of Chinese Medical Association (2006) Consensus on chronic gastritis in China (Part I) (2006, Shanghai.) Chinese Journal of Digestion, 27, 45-49.

[2]   de Paulsen, N., Brychzy, A., Fournier, M.-C., et al. (2001) Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)-/-clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 98, 1387-1392.

[3]   Lin, S. (2001) Clinical series of 100 traditional Chinese medical doctors in 100 years—Lin Peixiang. China Traditional Chinese Medicine Press, Beijing, 10, 99-117.

[4]   Wang, S.W., Shi, X.Y. and Huang, C.G. (2001) Pharmacodynamics research and evaluation of traditional Chinese medicine. Shaanxi Science and Technology Press, Xi’an, 315-317.

[5]   Xu, W.W. and Wang, M.Q. (2003) Observation of the curative effects of Weifuchun Tablets on chronic atrophic gastritis. Zhejiang Journal of Combination of Chinese Traditional and Western Medicine, 13, 505-506.

[6]   Poulsen, S.S., Kissow, H., Hare, K., Hartmann, B. and Thim, L. (2005) Luminal and parenteral TFF2 and TFF3 dimer andmonomer in two models of experimental colitis inthe rat. Regulatory Peptides, 126, 163-171. http://dx.doi.org/10.1016/j.regpep.2004.09.007

[7]   Leung, W.K., Yu, J., Chan, F.K., To, K.F., Chan, M.W., Ebert, M.P., Ng, E.K., Chung, S.C., Malfertheiner, P. and Sung, J.J. (2002) Ex-pression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia , and non-neoplastic gastric tissues. The Journal of Pathology, 197, 582-588. http://dx.doi.org/10.1002/path.1147

[8]   Suárez, C., Vizoso, F., Rodríguez, J.C., García, I., Raigoso, P., Allende, M.T., García-Muíz, J.L. and GarcíaMorán, M. (2001) Prognostic significance of cytosolic pS2 protein con-tent in gastric cancer. The International Journal of Biological Markers, 16, 37-44

[9]   Shiemann, U., Konturek, J., Assert, R., et al. (2002) mRNA expression of EGF receptor ligands in atrophic gastritis before and after helicobacter pylori eradication. Medical Science Monitor, 8, 53-58.

[10]   Alison, M.R., Chinery, R., Poulsom, R., et al. (1995) Experiment alulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. The Journal of Pathology, 175, 405-414. http://dx.doi.org/10.1002/path.1711750408

[11]   Nie, S.N., Sun, H.C., Wu, X.H., et al. (2005) The regulation of trefoil peptides on gastric adaptive cytoprotection. Chinese Critical Care Medicine, 17, 302

[12]   Susumu, A.K., Yasukazu, O., Toshiaki, G., et al. (2011) Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology, 141, 837-845, e7.

[13]   Im, S., Yoo, C.Y., Jung, J.-H., et al. (2013) Reduced expression of TFF1 and increased ex-pression of TFF3 in gastric cancer: Correlation with clinicopathological parameters and prognosis. Inter-national Journal of Medical Sciences, 10, 133-140.

 
 
Top